20 Nov Renovos Biologics, a biotechnology company that is harnessing nanotechnology to precisely deliver therapeutic agents for regenerative medicine, receives investment from Henley Business Angels members
Renovos Biologics, a biotechnology company that is developing a proprietary nanoclay gel carrier system to precisely deliver therapeutic agents for regenerative medicine, has received investment from five Henley Business Angels members, contributing towards a funding round, which together with non-dilutive grants, amounts to £2.3 million. The...